India’s first Covid-19 vaccine COVAXIN update: All you need to know
Registration of Volunteers for Human Trial of the country vaccine COVAXIN has started in Delhi AIIMS amid increasing cases of Coronavirus India Update in the country. Covaxin is India’s indigenous COVID-19 vaccine by Bharat Biotech. AIIMS Delhi to start the human trials of Covaxin from today.
Only 100 people can be included in this phase one trial in AIIMS. At the same time, more than 100 people have registered for the human trial of this vaccine (COVAXIN Human Trial) within a few hours. At the same time, human trials of this vaccine have already started in Patna AIIMS before AIIMS in Delhi and Rohtak PGIMS in Haryana.
BharatBiotech on Twitter:
“India’s First Indigenous COVID 19 Vaccine, COVAXIN™, initiated Phase-1 clinical trials across the country on 15th July 2020.”
The human trial at AIIMS (Delhi) have started after Drugs Controller General of India (DCGI), India’s top drug regulator, had recently given a green signal for Covaxin human clinical trials.
Also, Read: Ludo’, ‘A Suitable Boy’, ‘Gunjan Saxena: Netflix Announces 17 New Films And Series
